82 FR 23250 - Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), Lead Poisoning Prevention (LPP) Subcommittee
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC) Federal Register Volume 82, Issue 97 (May 22, 2017)
Centers for Disease Control and Prevention (CDC)
Federal Register Volume 82, Issue 97 (May 22, 2017)
| Page Range | 23250-23251 | |
| FR Document | 2017-10333 |
[Federal Register Volume 82, Number 97 (Monday, May 22, 2017)] [Notices] [Pages 23250-23251] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-10333] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR), Lead Poisoning Prevention (LPP) Subcommittee In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the CDC, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ATSDR) announces the following meeting of the aforementioned committee: Time and date: 9:00 a.m.-12:00 p.m. EDT, June 23, 2017. Place: The meeting will be accessible by teleconference. Please dial toll free 1-888-790-2009 Passcode: 7865774. Status: Open to the public, via teleconference line. No limit on number of lines. The public is welcome to participate during the Public Comment period which is scheduled from 11:00 a.m. until 11:15 a.m. EST (15 minutes). Individuals wishing to make a comment during Public Comment period, please email your name, organization, and phone number by Monday, June 15, 2017 to Amanda Malasky at [email protected]. Purpose: The subcommittee will discuss strategies and options on ways to prioritize NCEH/ATSDR's activities, improve health outcomes, and address health disparities as it relates to lead exposures. The subcommittee will deliberate on ways to evaluate lead exposure and how to best conduct health evaluations through exposure [[Page 23251]] and epidemiologic studies. Subcommittee proposals on lead prevention practices and national lead poisoning prevention efforts will be provided to the Board of Scientific Counselors for deliberation and possible adoption as formal recommendations to NCEH/ATSDR. Matters for Discussion: Agenda items will include the following: Lead Poisoning Prevention Program (status), Flint Registry (status), Revision of Blood Lead Level reference value (status), Discussion of legislative requirements of a new Lead Exposure and Prevention Federal Advisory Committee, Federal partnership efforts. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Amanda Malasky, Coordinator, Lead Poisoning Prevention Subcommittee, BSC, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F-45, Chamblee, Georgia 30345; telephone 770/488- 7699, Fax: 770/488-3377; Email: [email protected]. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-10333 Filed 5-19-17; 8:45 am] BILLING CODE 4163-18-P
![23250 Federal Register / Vol. 82, No. 97 / Monday, May 22, 2017 / Notices
obligations, these statutory provisions new compensation program. Key Officer, NIOSH, CDC, 1600 Clifton
provide the legal authorization for the functions of the Advisory Board include Road, Mailstop E–20, Atlanta, Georgia
collection of information on the FR providing advice on the development of 30333, Telephone (513) 533–6800, Toll
3016. The FR 3016 is a voluntary probability of causation guidelines that Free 1(800)CDC–INFO, Email ocas@
survey. No issue of confidentiality have been promulgated by the cdc.gov.
normally arises under the FR 3016, as Department of Health and Human The Director, Management Analysis
names and any other characteristics that Services (HHS) as a final rule; advice on and Services Office, has been delegated
would permit personal identification of methods of dose reconstruction, which the authority to sign Federal Register
respondents are not reported to the have also been promulgated by HHS as notices pertaining to announcements of
Board. However, should the Board a final rule; advice on the scientific meetings and other committee
obtain such information, it would likely validity and quality of dose estimation management activities, for both the
be exempt under exemption 6 of the and reconstruction efforts being Centers for Disease Control and
Freedom of Information Act (5 U.S.C. performed for purposes of the Prevention and the Agency for Toxic
552(b)(6)) to the extent that it includes compensation program; and advice on Substances and Disease Registry.
‘‘personnel and medical files and petitions to add classes of workers to the
Elaine L. Baker,
similar files the disclosure of which Special Exposure Cohort (SEC).
would constitute a clearly unwarranted In December 2000, the President Director, Management Analysis and Services
delegated responsibility for funding, Office, Centers for Disease Control and
invasion of personal privacy.’’
Prevention.
Board of Governors of the Federal Reserve
staffing, and operating the Advisory
Board to HHS, which subsequently [FR Doc. 2017–10332 Filed 5–19–17; 8:45 am]
System, May 17, 2017.
Ann E. Misback, delegated this authority to CDC. NIOSH BILLING CODE 4163–19–P
implements this responsibility for CDC.
Secretary of the Board.
The charter was issued on August 3,
[FR Doc. 2017–10331 Filed 5–19–17; 8:45 am]
2001, renewed at appropriate intervals, DEPARTMENT OF HEALTH AND
BILLING CODE 6210–01–P
rechartered on March 22, 2016 pursuant HUMAN SERVICES
to Executive Order 13708, and will
Centers for Disease Control and
expire on September 30, 2017.
DEPARTMENT OF HEALTH AND Purpose: The Advisory Board is Prevention (CDC)
HUMAN SERVICES charged with (a) providing advice to the Board of Scientific Counselors,
Secretary, HHS, on the development of National Center for Environmental
Centers for Disease Control and guidelines under Executive Order
Prevention Health/Agency for Toxic Substances
13179; (b) providing advice to the and Disease Registry (BSC, NCEH/
Secretary, HHS, on the scientific ATSDR), Lead Poisoning Prevention
Subcommittee for Dose
validity and quality of dose (LPP) Subcommittee
Reconstruction Reviews (SDRR),
reconstruction efforts performed for this
Advisory Board on Radiation and
program; and (c) upon request by the In accordance with section 10(a)(2) of
Worker Health (ABRWH or the
Secretary, HHS, advise the Secretary on the Federal Advisory Committee Act
Advisory Board), National Institute for
whether there is a class of employees at (Pub. L. 92–463), the CDC, National
Occupational Safety and Health
any Department of Energy facility who Center for Environmental Health/
(NIOSH)
were exposed to radiation but for whom Agency for Toxic Substances and
In accordance with section 10(a)(2) of it is not feasible to estimate their Disease Registry (NCEH/ATSDR)
the Federal Advisory Committee Act radiation dose, and on whether there is announces the following meeting of the
(Pub. L. 92–463), the Centers for Disease reasonable likelihood that such aforementioned committee:
Control and Prevention (CDC), radiation doses may have endangered Time and date: 9:00 a.m.–12:00 p.m.
announces the following meeting for the the health of members of this class. The EDT, June 23, 2017.
aforementioned subcommittee: Subcommittee for Dose Reconstruction Place: The meeting will be accessible
Time and Date: 10:30 a.m.–5:00 p.m., Reviews was established to aid the by teleconference. Please dial toll free
EDT, June 27, 2017. Advisory Board in carrying out its duty 1–888–790–2009 Passcode: 7865774.
Place: Audio Conference Call via FTS to advise the Secretary, HHS, on dose Status: Open to the public, via
Conferencing. reconstruction. teleconference line. No limit on number
Status: Open to the public, but Matters for Discussion: The agenda for of lines. The public is welcome to
without a public comment period. The the Subcommittee meeting includes the participate during the Public Comment
public is welcome to submit written following dose reconstruction program period which is scheduled from 11:00
comments in advance of the meeting, to quality management and assurance a.m. until 11:15 a.m. EST (15 minutes).
the contact person below. Written activities: Dose reconstruction cases Individuals wishing to make a comment
comments received in advance of the under review from Sets 14–23, during Public Comment period, please
meeting will be included in the official including the Oak Ridge sites (Y–12, K– email your name, organization, and
record of the meeting. The public is also 25, Oak Ridge National Laboratory), phone number by Monday, June 15,
welcome to listen to the meeting by Hanford, Feed Materials Production 2017 to Amanda Malasky at AMalasky@
joining the teleconference at the USA Center (‘‘Fernald’’), Mound Plant, Rocky cdc.gov.
toll-free, dial-in number at 1–866–659– Flats Plant, Nevada Test Site, Idaho Purpose: The subcommittee will
0537 and the pass code is 9933701. National Laboratory, Savannah River discuss strategies and options on ways
mstockstill on DSK30JT082PROD with NOTICES
Background: The Advisory Board was Site, and other Department of Energy to prioritize NCEH/ATSDR’s activities,
established under the Energy Employees and ‘‘Atomic Weapons Employer’’ improve health outcomes, and address
Occupational Illness Compensation facilities. health disparities as it relates to lead
Program Act of 2000 to advise the The agenda is subject to change as exposures. The subcommittee will
President on a variety of policy and priorities dictate. deliberate on ways to evaluate lead
technical functions required to Contact Person for More Information: exposure and how to best conduct
implement and effectively manage the Theodore Katz, Designated Federal health evaluations through exposure
VerDate Sep<11>2014 23:17 May 19, 2017 Jkt 241001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1](https://thefederalregister.org/doc/82_FR_23347/page/1.svg)
![Federal Register / Vol. 82, No. 97 / Monday, May 22, 2017 / Notices 23251
and epidemiologic studies. announcement and matters for DATES: The meeting will be held on June
Subcommittee proposals on lead discussion should read as follows: 20, 2017, from 8 a.m. to 5 p.m.
prevention practices and national lead The meeting announced below Comments received on or before June 6,
poisoning prevention efforts will be concerns the Centers for Disease Control 2017, will be provided to the committee.
provided to the Board of Scientific and Prevention (CDC) initial review of Comments received after that date will
Counselors for deliberation and possible applications in response to Funding be taken into consideration by the
adoption as formal recommendations to Opportunity Announcement (FOA) Agency.
NCEH/ATSDR. GH17–005, Conducting Public Health
Matters for Discussion: Agenda items Research in China. ADDRESSES: FDA White Oak Campus,
will include the following: Lead Time and Date: 9:00 a.m.–2:00 p.m., 10903 New Hampshire Avenue,
Poisoning Prevention Program (status), EDT, May 24, 2017 Building. 31 Conference Center, the
Flint Registry (status), Revision of Blood Matters for Discussion: The meeting Great Room (Rm. 1503), Silver Spring,
Lead Level reference value (status), will include the initial review, MD 20993–0002. Answers to commonly
Discussion of legislative requirements of discussion, and evaluation of asked questions including information
a new Lead Exposure and Prevention applications received in response to regarding special accommodations due
Federal Advisory Committee, Federal ‘‘Conducting Public Health Research in to a disability, visitor parking, and
partnership efforts. China’’, GH17–005. transportation may be accessed at:
Agenda items are subject to change as FOR FURTHER INFORMATION CONTACT: http://www.fda.gov/Advisory
priorities dictate. Hylan Shoob, Scientific Review Officer, Committees/AboutAdvisoryCommittees/
Contact Person for More Information: Center for Global Health (CGH) Science ucm408555.htm.
Amanda Malasky, Coordinator, Lead Office, CGH, CDC, 1600 Clifton Road,
FDA is establishing a docket for
Poisoning Prevention Subcommittee, NE., Mailstop D–69, Atlanta, Georgia
public comment on this meeting. The
BSC, NCEH/ATSDR, 4770 Buford 30033, Telephone: (404) 639–4796,
docket number is FDA–2017–N–1988.
Highway, Mail Stop F–45, Chamblee, CGHERPO@CDC.GOV.
The Director, Management Analysis All submissions received must include
Georgia 30345; telephone 770/488–
and Services Office, has been delegated the Docket No. FDA–2017–N–1988 for
7699, Fax: 770/488–3377; Email:
the authority to sign Federal Register ‘‘Endocrinologic and Metabolic Drugs
AMalasky@cdc.gov.
The Director, Management Analysis notices pertaining to announcements of Advisory Committee; Notice of Meeting;
and Services Office has been delegated meetings and other committee Establishment of a Public Docket;
the authority to sign Federal Register management activities, for both the Request for Comments.’’ For detailed
notices pertaining to announcements of Centers for Disease Control and instructions on sending comments, see
meetings and other committee Prevention and the Agency for Toxic the ‘‘Public Participation’’ heading of
management activities, for both the Substances and Disease Registry. the SUPPLEMENTARY INFORMATION section
Centers for Disease Control and of this document. You may submit
Elaine L. Baker, comments as follows:
Prevention and the Agency for Toxic Director, Management Analysis and Services
Substances and Disease Registry. Office, Centers for Disease Control and Electronic Submissions
Elaine L. Baker, Prevention.
Submit electronic comments in the
Director, Management Analysis and Services [FR Doc. 2017–10334 Filed 5–19–17; 8:45 am]
following way:
Office, Centers for Disease Control and BILLING CODE 4163–18–P
Prevention. • Federal eRulemaking Portal:
[FR Doc. 2017–10333 Filed 5–19–17; 8:45 am] https://www.regulations.gov/. Follow
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND the instructions for submitting
HUMAN SERVICES comments. Comments submitted
electronically, including attachments, to
DEPARTMENT OF HEALTH AND Food and Drug Administration https://www.regulations.gov/ will be
HUMAN SERVICES [Docket No. FDA–2017–N–1988] posted to the docket unchanged.
Because your comment will be made
Centers for Disease Control and Endocrinologic and Metabolic Drugs public, you are solely responsible for
Prevention Advisory Committee; Notice of ensuring that your comment does not
Meeting; Establishment of a Public include any confidential information
Disease, Disability, and Injury Docket; Request for Comments that you or a third party may not wish
Prevention and Control Special to be posted, such as medical
Emphasis Panel (SEP): Initial Review AGENCY: Food and Drug Administration, information, your or anyone else’s
HHS. Social Security number, or confidential
The meeting announced below ACTION: Notice; establishment of a
concerns the Centers for Disease Control business information, such as a
public docket; request for comments. manufacturing process. Please note that
and Prevention (CDC) initial review of
applications in response to Funding SUMMARY: The Food and Drug if you include your name, contact
Opportunity Announcement (FOA) Administration (FDA or Agency) information, or other information that
GH16–006, Conducting Public Health announces a forthcoming public identifies you in the body of your
Research in Kenya; GH17–004, advisory committee meeting of the comments, that information will be
Conducting Public Health Research Endocrinologic and Metabolic Drugs posted on https://www.regulations.gov/.
mstockstill on DSK30JT082PROD with NOTICES
Activities in Egypt; GH17–005, Advisory Committee. The general • If you want to submit a comment
Conducting Public Health Research in function of the committee is to provide with confidential information that you
China. advice and recommendations to the do not wish to be made available to the
This publication corrects a notice that Agency on FDA’s regulatory issues. The public, submit the comment as a
was published in the Federal Register meeting will be open to the public. FDA written/paper submission and in the
on May 4, 2017, Volume 82, Number 85, is establishing a docket for public manner detailed (see ‘‘Written/Paper
pages 20894–20895. The meeting comment on this document. Submissions’’ and ‘‘Instructions’’).
VerDate Sep<11>2014 23:17 May 19, 2017 Jkt 241001 PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1](https://thefederalregister.org/doc/82_FR_23347/page/2.svg)
Document Created: 2018-11-08 08:51:26
Document Modified: 2018-11-08 08:51:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 9:00 a.m.-12:00 p.m. EDT, June 23, 2017. | |
| FR Citation | 82 FR 23250 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR